Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 18,263 |
| Receivables | 0 | 90 |
| Other current assets | 0 | 236 |
| TOTAL | $0 | $18,589 |
| Non-Current Assets | ||
| PPE Net | N/A | 736 |
| Other Non-Current Assets | 0 | 3 |
| TOTAL | $N/A | $739 |
| Total Assets | $0 | $19,122 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 0 | 79 |
| Accounts payable and accrued liabilities | 0 | 2,929 |
| TOTAL | $0 | $3,058 |
| Non-Current Liabilities | ||
| Long Term Debt | 0 | 63 |
| Other Non-Current Liabilities | 61 | 8,742 |
| TOTAL | $N/A | $8,856 |
| Total Liabilities | $0 | $11,914 |
| Shareholders' Equity | ||
| Common Shares | 0 | 71,003 |
| Retained earnings | 0 | -77,281 |
| Other shareholders' equity | 0 | -3,364 |
| TOTAL | $0 | $7,208 |
| Total Liabilities And Equity | $0 | $19,122 |